Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4f4p | 0SB | Tyrosine-protein kinase SYK | 2.7.10.2 | 1.000 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.526 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.513 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.507 | |
3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.500 | |
3bqr | 4RB | Death-associated protein kinase 3 | / | 0.497 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.493 | |
4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.489 | |
4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.486 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.485 | |
2yaa | ATP | Death-associated protein kinase 2 | / | 0.484 | |
3orz | BI4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.482 | |
3kkv | B99 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.479 | |
2pvm | P29 | Casein kinase II subunit alpha | 2.7.11.1 | 0.478 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.478 | |
4l9i | 8PR | Rhodopsin kinase | / | 0.478 | |
3at4 | CCK | Casein kinase II subunit alpha | 2.7.11.1 | 0.476 | |
4i0t | 1B6 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.475 | |
1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.474 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.473 | |
3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.472 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.471 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.468 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.468 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.467 | |
3axw | TID | Casein kinase II subunit alpha | 2.7.11.1 | 0.465 | |
5av2 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.465 | |
2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.464 | |
3dqw | AGS | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.462 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.460 | |
4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
2f7z | 6EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.459 | |
3q9x | EMO | Casein kinase II subunit alpha | 2.7.11.1 | 0.459 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.458 | |
5av3 | KMP | Death-associated protein kinase 1 | 2.7.11.1 | 0.458 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.456 | |
3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.456 | |
2uzv | SS5 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.455 | |
2etr | Y27 | Rho-associated protein kinase 1 | 2.7.11.1 | 0.454 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.454 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.454 | |
3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.453 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.453 | |
1fvv | 107 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.452 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.452 | |
4fv2 | EK5 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.451 | |
2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.450 | |
2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.449 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.449 | |
3ofm | 4B0 | Casein kinase II subunit alpha' | 2.7.11.1 | 0.449 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.449 | |
4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2ojf | 4PY | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.448 | |
3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.448 | |
3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.448 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.447 | |
2uzu | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
4fv6 | E57 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.447 | |
3cqw | CQW | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.446 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.446 | |
1jkl | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.445 | |
2ojj | 82A | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.445 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.444 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.444 | |
5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.443 | |
3u4u | LNH | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
4dgm | AGI | Casein kinase II subunit alpha | 2.7.11.1 | 0.443 | |
4gv1 | 0XZ | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.443 | |
1q8u | H52 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
2vo0 | M03 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.441 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
4h4z | FAD | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.441 | |
2f7e | 2EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.440 | |
2wmq | ZYQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.440 |